Results for "[:.]-[:.]IU"

10 IU/mL

in healthy women: Non-pregnant premenopausal women: 97.5% of women have results ≤ 1 IU/L Postmenopausal women: 97.5% of women have results ≤ 7 IU/L (

/ml Equivocal 10-15 IU/ml Positive >15 IU/ml

Reference ranges <2.2 IU/L: Negative 2.2-3.3 IU/L: Equivocal >3.3 IU/L: Positive Further information For further information about thyroid antibody testing

doses of Rubella vaccine or; one documented dose of vaccine followed by one Rubella IgG antibody screening test with detectable antibody greater than 10 iu

0.5-2.0 iu/ml

/mL levels conferring some protection: 0.016 to 0.09 IU/mL protective levels: 0.1 to 0.9 IU/mL levels conferring long-term protection: >1 IU/mL

iu/ml

Reference ranges Serum hCG levels in healthy women: Non-pregnant premenopausal women: 97.5% of women have results ≤ 1 iU/L Postmenopausal women: 97.5%

Reference ranges  Adult (male & female) < 1 IU/L Post-menopausal & mid cycle <3 IU/L Note: In pregnancy there is 0.1% cross-reactivity with hCG.

Range (IU/ml)

/mL and log IU/mL

LH (IU/L)

Sample Requirements Adult 5ml Gold-top SST tube Paediatric 1ml Serum Sample Turnaround Times 7 days Reference Ranges 0-14 IU/ml Assay Interferences

Microbiology Notes The routine pregnancy test has a sensitivity of 25 IU/L.

Reference ranges 0-18 years: 29-112 IU/L ≥ 19 years: 16 to 85 IU/L Further information To learn more about ACE visit Lab Tests Online Page last updated

However in the setting of HIV infection, severe immunocompromise and ocular Toxoplasma infection a lower threshold of <4 iu/ml is taken as negative and

iu/ml Heparin

iu/dl

Reinforcing doses of vaccine should be given if serology indicates that antibody levels are below a protective antibody titre of at least 0.5 IU/mL (WHO